Phathom Pharmaceuticals, Inc. (PHAT) vs Replimune Group, Inc. (REPL)
Detailed comparison between Phathom Pharmaceuticals, Inc., Replimune Group, Inc..Total Return (%)
Phathom Pharmaceuticals, Inc. (PHAT)Replimune Group, Inc. (REPL)
Which stock do you think will perform better?
Phathom Pharmaceuticals, Inc.
PHAT
Replimune Group, Inc.
REPL
| Metric | Phathom Pharmaceuticals, Inc. (PHAT) | Replimune Group, Inc. (REPL) |
|---|---|---|
| Current Price | $4.03 | $7.78 |
| Change | -0.19 (-4.62%) | 0.14 (1.90%) |
| Market Cap | $0.28B | $0.60B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.01 | -2.89 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $19.71 | $17.00 |
| 52-Week Low | $3.81 | $4.92 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.29 | $-3.07 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| PHAT | -35.31% | -40.65% | -55.27% | -86.63% | -83.62% | -83.62% |
| REPL | -28.14% | -34.39% | 21.11% | -30.52% | -48.71% | -48.71% |